Viewing nowLipican Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 200703136 · Notified 2007.03.13 · Insurance code 653801370
Improvement of hyperlipidemia (including familial hyperlipidemia in children, etc.) and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke, and also reduces the risk of vascular surgeries and angina. It is effective at managing multiple risk factors for cardiovascular diseases in diabetic patients. In patients with hyperlipidemia, it helps improve vascular health by regulating cholesterol and triglyceride levels. Additionally, it aids in the prevention of heart disease in pediatric patients with familial hypercholesterolemia. Overall, it is used to improve cardiovascular health and reduce risks.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma atorvastatin concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).
This drug may pose a risk of muscle problems; therefore, if symptoms of muscle pain or weakness occur, you should stop taking it immediately and consult a doctor. Patients with liver dysfunction or severe liver disease should not use this medication and should undergo regular liver function tests during treatment. Women who are pregnant or may become pregnant should not take this medication and must use proper contraceptive methods while on it. This drug may increase the risk of side effects when taken with certain medications, so if you are taking other drugs, you should inform your doctor or pharmacist. Elderly patients or those with decreased kidney function are at higher risk for muscle-related side effects, so caution is needed during use, and symptoms should be reported immediately. This medication contains lactose, so individuals with lactose intolerance should not take it. Since there is no specific antidote for overdose, if an overdose occurs, immediate medical treatment should be sought, and liver function and muscle status should be carefully monitored. Keep out of reach of children, store in the original container to prevent misuse or deterioration in quality. If allergic reactions such as skin rash, itching, or difficulty breathing occur, stop taking this medication immediately and consult medical personnel.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is not exposed to air, preferably at room temperature between 1 and 30 degrees Celsius. By storing it this way, you can maintain the effectiveness of the medicine for an extended period.
White oval film-coated tablet
30 tablets/bottle, 120 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.